Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019.

Saved in:
Bibliographic Details
Title: Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019.
Authors: Oulee A; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Javadi SS; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Ahn GS; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Maul JT; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Wu JJ; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida.
Source: Cutis [Cutis] 2022 Oct; Vol. 110 (4), pp. 212-214.
Publication Type: Letter
Journal Info: Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 0006440 Publication Model: Print Cited Medium: Internet ISSN: 2326-6929 (Electronic) Linking ISSN: 00114162 NLM ISO Abbreviation: Cutis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36446100
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Oulee+A%22">Oulee A</searchLink>; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida.<br /><searchLink fieldCode="AU" term="%22Javadi+SS%22">Javadi SS</searchLink>; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida.<br /><searchLink fieldCode="AU" term="%22Ahn+GS%22">Ahn GS</searchLink>; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida.<br /><searchLink fieldCode="AU" term="%22Maul+JT%22">Maul JT</searchLink>; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida.<br /><searchLink fieldCode="AU" term="%22Wu+JJ%22">Wu JJ</searchLink>; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220006440%22">Cutis</searchLink> [Cutis] 2022 Oct; Vol. 110 (4), pp. 212-214.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontline+Medical+Communications%22">Frontline Medical Communications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0006440 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6929 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200114162%22">00114162 </searchLink><i>NLM ISO Abbreviation: </i>Cutis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36446100
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.12788/cutis.0625
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 212
    Titles:
      – TitleFull: Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Oulee A
      – PersonEntity:
          Name:
            NameFull: Javadi SS
      – PersonEntity:
          Name:
            NameFull: Ahn GS
      – PersonEntity:
          Name:
            NameFull: Maul JT
      – PersonEntity:
          Name:
            NameFull: Wu JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6929
          Numbering:
            – Type: volume
              Value: 110
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cutis
              Type: main
ResultId 1